MENU
+Compare
IWINQ
Stock ticker: OTC
AS OF
Dec 3 closing price
Price
$0.21
Change
-$0.00 (-0.00%)
Capitalization
711.4K

IWINQ Irwin Naturals Inc. Forecast, Technical & Fundamental Analysis

Irwin Naturals Inc develops vitamins and other health supplements and distributes these products in the United States and Canada through two main channels: health food stores and mass market retailers... Show more

IWINQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for IWINQ with price predictions
Nov 28, 2025

IWINQ's RSI Oscillator descends into oversold zone

The RSI Oscillator for IWINQ moved into overbought territory on November 28, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.099) is normal, around the industry mean (3.080). P/E Ratio (0.000) is within average values for comparable stocks, (42.226). IWINQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.283). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (0.008) is also within normal values, averaging (6.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IWINQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IWINQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

View a ticker or compare two or three
IWINQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry DrugstoreChains

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RMBS96.212.02
+2.14%
Rambus
CXW18.280.35
+1.95%
CoreCivic
UYSCU10.22-0.10
-0.97%
Uy Scuti Acquisition Corp
KBSX1.40-0.02
-1.41%
FST Corp
AURA6.02-0.19
-3.06%
Aura Biosciences

Groups containing IWINQ

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IWINQ
1D Price
Change %
IWINQ100%
N/A
Drugstore Chains
industry (20 stocks)
0%
Poorly correlated
+0.68%
Retail Trade
industry (414 stocks)
-5%
Poorly correlated
+0.41%